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Purpose: Contractile activity of the trabecular meshwork (TM) and ciliary muscle (CM) influences aqueous humor
drainage; however, the mechanisms linking tissue contractility and regulation of aqueous humor drainage are not well
understood. Regulator of G Protein Signaling 2 (RGS2), a GTPase-activating protein of the Gαq family of proteins, plays
a critical role in regulation of contractile activity of vascular smooth muscle and in blood pressure homeostasis. To explore
a potential role for RGS2 in intraocular pressure (IOP) homeostasis, we evaluated RGS2 knockout (RGS2−/−) mice for
changes in IOP.
Methods: IOP was measured using a rebound tonometer in awake male RGS2−/− and littermate wild-type mice.
Histological and immunofluorescence analyses were performed to evaluate changes in the iridocorneal structure,
actomyosin organization in CM and TM, and retinal ganglion cell survival in both central and peripheral retina.
Results: In repeated measurements, IOP was found to be consistently lower in the RGS2−/− mice compared to littermate
wild-type mice. This change in IOP appears to be associated with increased actin filament assembly in the CM, and
widening of the Schlemm’s canal in the aqueous humor drainage pathway. Furthermore, ganglion cell number in the
central retina was found to be significantly higher in the RGS2−/− mice relative to wild-type mice.
Conclusions: The data suggest that the deficiency of RGS2 decreased IOP, presumably due to increased aqueous humor
drainage in association with increased CM contraction. These data indicate a potentially critical role for RGS2 in
homeostasis of IOP and for retinal ganglion cell survival.
Glaucoma is a major cause of irreversible blindness
worldwide. Elevated intraocular pressure (IOP) due to
impaired aqueous humor drainage can cause optic nerve
damage and death of retinal ganglion cells, leading to
blindness [1,2]. Therefore, there is a great need for
understanding the regulation of aqueous humor drainage and
finding the molecular targets for novel treatment of increased
IOP in glaucoma patients. IOP depends on a balance between
aqueous humor secretion from the ciliary body (CB)
epithelium and aqueous humor outflow in the trabecular
meshwork (TM) [1,3]. In open angle glaucoma patients, it is
generally believed that the production of aqueous humor is
not increased, but that drainage is impaired due to increased
resistance at a level in the outflow pathway close to the inner
wall of Schlemm’s canal (SC) [4]. Aqueous humor is drained
predominantly through conventional route, consisting of the
TM, juxtacanalicular area, and SC [4,5].
Cellular contraction and relaxation properties of both TM
and ciliary muscle (CM) have been reported to influence
aqueous humor outflow, and thus IOP [3,4,6]. Both TM and
CM exhibit smooth muscle-like properties and contain
functional muscarinic, α-adrenergic, and β-adrenergic
receptors [3,6]. Interestingly, the contractile status of TM and
CM has been demonstrated to exert antagonistic effects on
aqueous humor outflow, with contraction of the TM leading
to decreased aqueous humor outflow, and CM contraction
causing increases in aqueous humor drainage [3,4,6].
Moreover, several studies have demonstrated the influence of
the Rho GTPase/Rho kinase pathway, myosin II, myosin light
chain kinase, and actin polymerization on aqueous humor
drainage via the TM outflow pathway [4,7,8]. The Rho/Rho
kinase pathway regulates smooth muscle contraction in a
calcium-independent manner via myosin II phosphorylation
[9]. Agonists of G-protein coupled receptors (GPCR),
including angiotensin II, thromboxane A2, lysophosphatidic
acid, endothelin-1, and thrombin, induce Rho GTPase
activation and myosin light chain (MLC) phosphorylation in
TM cells. Perfusion with some of these agonists has been
observed to decrease aqueous humor outflow in enucleated
eyes [6,10,11], yet inhibition of Rho/Rho kinase and myosin
II phosphorylation in the trabecular outflow pathway
increases aqueous humor outflow [7]. Taken together, though,
these different observations strongly support a potential role
for several signaling mechanisms (e.g., GPCR and Rho/Rho
kinase-dependent pathways) in the regulation of aqueous
humor outflow, the role of these different signaling pathways
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in mediating the effects of TM and CM contractility on IOP
homeostasis is yet to be delineated.
Because TM and CM are smooth muscle-like, we
hypothesized that regulator of G-protein signaling 2 (RGS2),
a regulatory protein that promotes vascular smooth muscle
relaxation and blood pressure homeostasis [12-15], might
control IOP. RGS2 is one of more than 20 RGS proteins that
regulate signaling via GPCRs in part by accelerating the
deactivation rates of Gα subunits via GTP hydrolysis [16,
17]. RGS2 preferentially deactivates Gαq [18], which
mediates signaling by GPCRs for many important
vasoconstrictors including angiotensin II, endothelin-1, and
vasopressin signal [19,20]. Activated Gαq in turn triggers
smooth muscle contraction via phospholipase C-induced Ca2+
release and subsequent increase in MLC phosphorylation by
calcium/calmodulin-dependent MLC kinase [21,22]. Gαq can
also trigger Rho GTPase signaling by certain Rho exchange
factors [21,22]. Homozygous deletion of RGS2 in mice
increases blood pressure by impairing the ability of the nitric
oxide-cGMP pathway to promote vascular relaxation because
inhibition of vasoconstrictor-triggered Gαq signaling is
abrogated [14,15].
To explore a potential role of RGS2 and Gαq-coupled
GPCR signaling in IOP homeostasis, we examined RGS2
knockout mice (RGS2−/−) for changes in IOP in this study.
Here we report decreased IOP and increased retinal ganglion
cell survival in RGS2−/− mice, possibly a result of increased
CM contraction.
METHODS
Animals: We used the well characterized homozygous RGS2
knockout (RGS2−/−) mouse strain along with the littermate
wild-type mice obtained from the Blumer laboratory,
Washington University School of Medicine, St. Louis, MO
[13]. The genetic background of this mouse strain was
C57BL/6. Polymerase chain reaction (PCR)-based
genotyping was performed using tail DNA to select the
RGS2−/− mice. Male RGS2−/− mice 12 to 15 months old and
littermate wild-type mice were used in this study. All animal
procedures were conducted in accordance with the
Association for Research in Vision and Ophthalmology
(ARVO) statement for the use of animals in ophthalmic and
vision research, under an approved Duke University
institutional animal protocol. Animals were maintained under
a standard 12 h:12 h light-dark cycle. Food and water were
available ad libitum.
IOP measurement: IOP was measured using a rebound
tonometer (Tiolat OY, Helsinki, Finland) according to the
manufacturer’s protocol and as described by Wang et al.
[23]. Briefly, the wild-type and RGS2−/− mice were gently
restrained in a clear, cone-shaped plastic bag with their heads
facing out, and they were tied to the flat plastic stand as
described by Wang et al. [23]. Prior to IOP measurements,
0.5% proparacaine anesthetic solution (Bausch & Lomb,
Tampa, FL) was applied to the eyes. IOP was measured in
both left and right eyes between 11 AM and 4 PM (12 h day
light cycle is from 7 AM to 7 PM), and each value was based
on an average of five independent tonometer readings. IOP
measurements were performed once a week for five weeks on
the same animals. Changes in IOP values between the
RGS2−/− and littermate wild-type mice were compared at
weekly intervals as well as based on the average value of five
independent weekly measurements. IOP was expressed per
eye, and the sample number was 10 in each group.
Histology: The mice were euthanized with intraperitoneal
injection (150 mg/kg bodyweight) of sodium pentobarbital
solution (obtained from Ovation Pharmaceuticals, Inc.,
Deerfield, IL) and followed by a heart puncture. Eyes were
enucleated immediately from both wild-type and RGS2−/−
mice and fixed in cold 0.1 M cacodylate buffer, pH 7.3,
containing 2.5% glutaraldehyde for at least 2 h. Then the eyes
were dissected into anterior and posterior segments and rinsed
twice for 15 min with 0.1 M cacodylate buffer. These tissue
specimens were postfixed in 0.1 M cacodylate buffer
containing 1% osmium tetroxide for 1.5 h at room temperature
and rinsed twice for 15 min with cacodylate buffer. The tissue
specimens were dehydrated with a series of ethanol (50 to
100%) and propylene oxide, and embedded with Spurr resin.
Next 0.8 µm sections, cut with a microtome, were stained with
1% methylene blue, and images were captured using a light
microscope (Zeiss Axioplan2, Carl Zeiss Microimaging, Inc.,
Thornwood, NY). The area and perimeter (total length) of SC
in the RGS2−/− and wild-type mice were estimated using
Metamorph software (Molecular Devices, Downingtown,
PA).
Immunohistochemistry: Freshly enucleated mouse eyes were
initially fixed in 4% paraformaldehyde at 4 °C for 1 h and then
dissected into anterior and posterior segments. These tissues
were further fixed in 4% paraformaldehyde for 2 h at 4 °C,
washed with phosphate buffered saline (PBS, consisting of
1.5 mM KH2PO4, 2.7 mM Na2HPO4, and 155 mM NaCl) and
cryoprotected in 5% sucrose overnight. The tissue specimens
were then shifted to 30% sucrose and incubated overnight
before embedding in Optimal Cutting Temperature compound
(Tissue-Tek obtained from Sakura Finetek, Torrance, CA)
and cryosectioning by cryotome (Microm HM550, Microm,
Germany). The tissue cryosections derived from the anterior
segment (8 µm) and posterior segment (10 µm) were air dried,
washed three times in PBS, and incubated with Image-iT FX
Signal Enhancer (Molecular Probes, Eugene, OR) for 30 min.
The anterior sections were washed three times in PBS
containing 0.3% Triton X-100 for 2 min, and blocked with 3%
fetal bovine serum for 2 h at 4 °C. The blocked sections were
incubated with phalloidin conjugated with tetra rhodamine
isothiocyanate (Sigma-Aldrich, St. Louis, MO) for 20 min at
room temperature. Retinal sections (posterior segments) for
ganglion cell staining were washed three times in PBS for 2
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min each and incubated in 0.5% Triton X-100 for 5 min. After
a wash with PBS, the sections were blocked with 10% donkey
serum for 2 h at 4 °C and incubated overnight at 4 °C with
1:25 dilution polyclonal Brn-3 primary antibody, which is
known to react with Brn-3a, Brn-3b, and Brn-3c subtypes
(Cat. No. Sc-6026; Santa Cruz Biotechnology, Santa Cruz,
CA). After three 5 min washes with PBS, the specimens were
incubated with a 1:100 dilution anti-goat IgG coupled to
Alexa-594 (Molecular Probes) for 2 h at room temperature.
The tissue sections were washed with PBS for 5 min and co-
stained with Hoechst 33258 (Invitrogen, Carlsbad, CA) for 15
min. Slides were mounted with Fluoromount-G (Southern
Biotech, Birmingham, AL). Fluorescence images were
captured using a Nikon EclipseC90i microscope (Nikon,
Tokyo, Japan) and analyzed with Metamorph software.
Retinal ganglion cell counting: Three retinal cryosections per
eye were fixed on each slide, and four slides per eye, from
both wild-type and RGS2−/− mice, were immunostained for
Brn-3, a marker of ganglion cells, as described in the previous
section. Four individual tissue sections were counted for
Brn-3 positive cells. Brn-3 positive cells and the total number
of nuclei in the ganglion cell layer of the retina based on
Hoechst staining were counted manually per 750 μm of retina,
and the values of four independent sections of the same eye
were averaged. These cell counts were performed for the
central and peripheral retina, and differences in the cell count
between the wild-type and RGS2−/− mice were determined.
Cell culture: To confirm the expression of RGS2 and Gαq in
TM and CB cells, we isolated human TM and human CB cells
from human donor eyes by digesting the TM tissue with Type
IV collagenase as described previously [24]. The cells were
cultured in Dulbecco’s Modified Eagle Medium with 10%
fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml
streptomycin at 37 °C under 5% CO2.
Reverse transcriptase-polymerase chain reaction: Reverse
transcriptase-polymerase chain reaction (RT–PCR) analysis
was performed on RGS2 and Gαq. Both human TM and CB
cells were grown to confluence, and total RNA was extracted
using the Rneasy Micro kit (Qiagen, Valencia, CA) according
to the manufacturer’s instructions. Total RNA was used for
reverse transcription, which was performed with the
Advantage® RT-for-PCR kit (Clontech, Mountain View,
CA). PCR amplification was performed using the Choice-
TaqTM DNA polymerase kit (Denville Scientific, Metuchen,
NJ) and the following gene-specific oligonucleotide primers:
RGS2: (5′-GGC TGC TTT ACA ACT GCC AGA A-3′/5′-
GTT TCC TGA ACA CCC AGG CTG AA-3′) and Gαq: (5′-
CCC TGC CTA CCT GCC TAC GCA ACA A-3′/5′-TGT
GGC GCA CGT GAA GTG GGA GTA G-3′). Controls
having no RT were included. Prior to RT reactions, total RNA
was treated with DNase-1 to eliminate DNA contamination.
Statistical analysis: Results were presented as the mean plus
or minus standard error (SEM), and statistical significance
was evaluated by the Student’s t test. A value of p<0.05 was
considered significant.
RESULTS
To determine the effects of RGS2, a negative regulator of
Gαq on IOP homeostasis, we monitored IOP changes in mice
with homozygous deletion of RGS2, using a rebound
tonometer. These measurements were performed in conscious
12- to 15-month-old mice. IOP was recorded five times on the
same animals (both wild-type and RGS2−/−) at a weekly
interval. The order of IOP measurements between the
RGS2−/− and wild-type mice was random.
IOP, based on average values of 10 eyes (both left and
right), was found to be consistently lower in the RGS2−/− mice
compared to the littermate wild-type mice measured over five
independent occasions (Figure 1A-E). While the average IOP
in wild-type mice was found to be above 20 mmHg (ranging
from 18 to 25 mmHg), it was below 18 mmHg (ranging from
14 to 20 mmHg) in the RGS2−/− mice. Additionally, based on
the average values of IOP derived from five independent
measurements (Figure 1F), IOP was found to be significantly
(p<0.05) lower in the RGS2−/− mice (17.98±1.34 mmHg)
compared to the wild-type mice (21.39±2.88 mmHg).
To gain insight into the IOP changes in the RGS2−/− mice
(Figure 1), we performed histologic studies of the iridocorneal
angle structure. Figure 2 illustrates the iridocorneal structure
of the RGS2−/− and wild-type mice. While there were no
obvious differences between the RGS2−/− and wild-type mice
in the iridocorneal structure (including TM and CB; Figure
2A), the SC area was found to be 80% larger in the RGS2−/−
mice compared to the wild-type mice (based on Metamorph
analysis; n=6; Figure 2B). The difference in perimeter (the
total length or circumference) of SC between the RGS2−/− and
wild-type mice, however, was not significant. The thickness
of sclera (in μm) over the aqueous humor drainage angle in
the RGS2−/− mice appears to be marginally thinner (78.0±6.8)
than in the wild-type mice (90.7±22.4); however, the
difference was not found to be significant (p<0.6) between the
two groups of mice. The values are based on six samples and
expressed as mean±SEM.
To obtain further insight into the observed increase in SC
area in the RGS2−/− mice, we evaluated possible changes in
the actin cytoskeletal organization of the iridocorneal angle.
The iridocorneal cryosections derived from the RGS2−/− and
wild-type mice were stained for actin filaments with
rhodamine phalloidin, and the distribution of actin filaments
in the iridocorneal angle was recorded using a fluorescence
microscope. Interestingly, the specimens of the RGS2−/− mice
revealed increased actin filament staining in the CM and TM
areas with relatively stronger staining in the CM as compared
to the wild-type specimens. Representative images derived
from two independent RGS2−/− (Figure 3C,D) and wild-type
(Figure 3A,B) mice are shown in Figure 3. Figure 3E-H
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illustrates the images taken under bright-field of the same
sections stained for the actin filament (Figure 3A-D). The
results represent the observations based on four independent
specimens. The increased actin filament staining in the CM
and TM indicates induced actomyosin assembly and
contraction, perhaps due to augmented Gαq-dependent GPCR
signaling in the RGS2−/− mice.
Primary cultures of human CB and TM cells were
confirmed to express both RGS2 and Gαq based on RT–PCR
analysis (data not shown). Elevated IOP from impaired
aqueous humor drainage has been well recognized to
influence the survival status of retinal ganglion cells [25,26].
Therefore, the RGS2−/− mice that showed a significant
decrease in IOP compared with wild-type mice (Figure 1F)
were evaluated for changes in retinal ganglion cell count.
Since glaucoma is an age-related disease, we used 12- to 15-
month-old RGS2−/− and wild-type mice to evaluate the chronic
effects of RGS2 deficiency on retinal ganglion cell count
using tissue cryosections derived from the central and
peripheral retina. The retinal tissue cryosections were
immunolabeled for Brn-3 (red staining), a well characterized
Pit-Oct-Unc (POU) domain protein and extensively used
ganglion cell marker [27]. The same tissue specimens were
also labeled with Hoechst (blue staining) to count the total
number of cells. Both the Brn-3-positive cells and total
number of nuclei (Hoechst positive) were manually calculated
for the same region and expressed per unit area of the retina.
Figure 4A-F shows representative fluorescence images
of Brn-3-positive cells and Hoechst-positive cells derived
from the RGS2−/− and wild-type mice, as well as superimposed
images of the Brn-3 and Hoechst labeling. The number of
Brn-3-positive cells in the ganglion cell region of the central
retina was found to be significantly higher (20% higher than
corresponding controls; p<0.05) in the RGS2−/− mice than in
the wild-type mice (Figure 4G). In the peripheral retina,
however, there was no difference in the Brn-3 positive cells
between the two groups of mice. The total number of cell
nuclei in the ganglion cell region of the central retina was
found to be marginally higher in the RGS2−/− mice but not
significantly different from the wild-type mice (Figure 4H).
The increased Brn-3-positive cells in the ganglion cell layer
of the central retina indicates increased retinal ganglion cell
survival in the RGS2−/− mice compared to the littermate wild-
type mice.
DISCUSSION
IOP homeostasis is critically important for both the health of
the optic nerve head and retinal ganglion cell survival, and
ultimately for normal vision. Increased IOP linked to impaired
aqueous humor drainage has been considered a major risk
factor for glaucoma [1]. Although various agonists and
antagonists of GPCRs have been documented to influence
aqueous humor outflow and IOP, very little is known about
the identity of predominant GPCR signaling pathways
Figure 1. Intraocular pressure changes
in the RGS2−/− mice. Diurnal IOP was
measured in both right and left eyes in
conscious animals, using a rebound
tonometer. Measurements were
performed five times on the same
animals at weekly intervals A-E: IOP
changes in the RGS2−/− mice were
compared with those of wild-type (WT)
mice recorded over five different days.
F: IOP changes between the wild-type
and RGS2−/− mice, based on the average
of five independent measurements, are
shown in panel A-E. Each error bar
represents the mean±SEM (n=8–10
eyes). Asterisk represents p<0 0.05.
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regulating aqueous humor outflow and IOP [3,4,6,10,11,
28-30]. To explore the involvement of Gαq-coupled GPCR
signaling in IOP homeostasis, we evaluated IOP changes in
RGS2 null mice (RGS2−/−) in this study. Gαq is a GPCR-
coupled G-protein that stimulates the contractile activity of
smooth muscle [21,22]. RGS2 serves as a negative regulator
of Gαq by accelerating its GTPase activity and thereby
terminating the signal response of Gαq [16,17]. RGS2−/− mice
showed a decrease in IOP in repeated measurements, and this
effect appeared to be associated with an increase in the width
of the SC, likely due to increased actomyosin assembly and
the resultant increase in tissue contractility in the ciliary
muscle.
The mean value of diurnal IOP in the RGS2−/− mice was
found to be 17.98±1.34 mmHg compared to
21.39±2.88 mmHg in littermate wild-type mice. Based on
several published reports on the rodent glaucoma model, the
difference of roughly 3.4 mmHg IOP observed in the RGS2−/
− mice is considered to be physiologically significant
[31-33]. Moreover, this decreased IOP in the RGS2−/− mice is
likely a chronic response stemming from the deletion of
RGS2. In this study, the nocturnal IOP was not monitored;
however, since nocturnal IOP is higher relative to the diurnal/
sleep period in rodents [32,34], it is possible that the lowered
IOP (diurnal) observed in RGS2−/− mice is indicative of a
much more significant drop in the IOP associated with the
nocturnal period.
Interestingly, the lowered IOP in the RGS2−/− mice was
found to be associated with an increase in the SC area, owing
to a widening of the SC. Although the specific mechanisms
responsible for the observed widening of the SC in the
RGS2−/− mice are not known (Figure 2), this observation
suggests a possible mechanical deformation of SC. Agonists,
such as pilocarpine and other miotics, have been shown to
cause mechanical deformation of TM and SC due to increased
CM contraction, resulting in increased aqueous humor
outflow and decreased IOP [5,6,35]. The tendons arising from
the anterior tips of the ciliary muscle insert into the TM and
well into the subendothelial region adjacent to the inner wall
of the SC [36]. Due to this intimate anatomic relationship
between the TM and the CM, when CM contraction is induced
by pilocarpine and other miotics, it has been shown to cause
TM expansion and widening of the SC and ultimately
decreasing outflow resistance [35-37]. The muscarinic
receptors (M1 and M3) that are coupled to Gαq have been
reported to be expressed in the CM and TM [6,28,30,38-40].
Therefore, we speculate that the increased SC area in the
RGS2−/− mice might potentially be due to altered geometry of
the aqueous outflow pathway in response to increased CM
contraction. For SC morphology we used six individual eyes
from each group (RGS2−/− and control), and these animals
were euthanized in three different batches on different days.
We saw distinct and consistent changes in the RGS2 −/− mice
as compared to wild-type mice, thus it is unlikely that these
observations represent the result of fixation artifact.
Figure 2. Iridocorneal histological changes in the RGS2−/− mice. A: Iridocorneal histological analysis was performed to examine structural
differences in the aqueous humor outflow pathway and ciliary body between the RGS2−/− and wild-type mice. The structural integrity of the
trabecular meshwork (TM), ciliary body (CB), and ciliary muscle (CM) were found to be comparable between the two groups of mice. However,
the Schlemm’s canal (SC) area was found to be significantly larger in the RGS2−/− mice compared to the littermate wild-type mice. B:
Quantitative changes in the SC area between the RGS2−/− and wild-type mice based on Metamorph pixel analysis. Values are shown as mean
±SEM (n=6). Asterisk represents p<0.05. Abbreviations: sclera (SCL), retina (RT).
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In support of the hypothesis of increased contraction of
the CM in RGS2−/− mice, we also noted an increased staining
for actin filaments in the CM, indicating induced contractile
actomyosin assembly. The TM tissue also exhibited an
increase in actin filament assembly based on phalloidin
staining; however, F-actin staining in the CM was much
higher relative to that noted in the TM (Figure 3). Increased
myosin II phosphorylation via sustained activation of Gαq
signaling in the RGS2−/− mice was expected to induce
actomyosin assembly, leading to enhanced contraction [22,
41], and our results of increased actin filament staining in the
CM of RGS2−/− mice supported this possibility. Additionally,
impaired nitric oxide-cGMP mediated relaxation which is
known to occur in RGS2−/− mice might also have contributed
significantly to observed increase in CM actomyosin
assembly [12,14,15,42-44]. Though additional biochemical
studies are necessary to support this contention, the RGS2−/−
mice have been reported to develop systemic hypertension
due to impaired vascular smooth muscle relaxation [12,13,
15,42]. Moreover, it has been reported that the expression and
regulation of RGS2 activity plays a critical role in regulation
of vascular endothelial contraction and blood pressure
homeostasis [45]. Therefore, changes in RGS2 expression in
the outflow pathway and ciliary body might also influence
IOP.
IOP values obtained in this study were noted to be slightly
higher than reported values for the mouse species [23,46],
This discrepancy might have stemmed from the lack of use of
general anesthesia in this study. The use of anesthetics has
been shown to lower IOP significantly [23,47]. However, it
also important to note that, unlike the studies reported by
Wang et al. [23], the rebound tonometer was not steadied and
fixed during the course of acquiring IOP measurements in our
studies. Since agitation of mice has been shown to cause
elevated IOP [23], any stress or agitation caused by routine
physical handling might also be a contributory factor in the
higher IOP values obtained in our study.
Both RGS2 and Gαq were confirmed to be expressed in
the TM and CM tissues, however, regulation of RGS2
expression in these tissues is not known. Importantly, RGS2
expression has been shown to be influenced by various
pharmacological and physiologic agents in different tissues
[48-51]. Therefore, in future studies, analysis of RGS2
expression in the CM and TM tissues of glaucomatous and
age-matched normal eyes might provide significant insight
into the role of RGS2 in the pathophysiology of glaucoma.
Since IOP is determined by the balance between aqueous
Figure 3. Changes in actin filament staining at the iridocorneal angle of the RGS2−/− mice. Cryosections of the eye anterior chamber including
the iridocorneal region derived from the RGS2−/− and wild-type mice were labeled for filamentous actin with rhodamin-phalloidin, and
fluorescence images were recorded. Actin filament staining (bright red fluorescence) in the ciliary muscle (CM) and trabecular meshwork
(TM) of the RGS2−/− mice (C and D) was found to be more intense relative to the wild-type mice (A and B), with much stronger staining in
the ciliary body (CB) as opposed to the TM. Panels E-H show images of the same specimens stained for the actin filaments (A-D), but recorded
under bright-field settings. Abbreviations: retina (RT); Schlemm’s canal (SC); sclera (SCL). Scale bar represents 50 µm.
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outflow and inflow [3], it is also necessary to exercise caution
while interpreting the results of lowered IOP in RGS2 −/− mice,
particularly with regard to whether this response is solely due
to increased aqueous outflow through the TM or also partly
owing to decreased secretion of aqueous humor by the ciliary
epithelium. Episcleral venous pressure is recognized to
potentially influence IOP [52]. However, we did not monitor
changes in episcleral venous pressure in the RGS2−/− mice.
Thus, it remains to be determined whether there was any
influence of episcleral venous pressure on the observed
changes in IOP in the RGS2−/− mice.
Since elevated IOP has been shown to influence retinal
ganglion cell survival [25,26,53,54], we also evaluated
changes in the retinal ganglion cell count in the RGS2−/− mice
by immunofluorescence analysis using Brn-3 antibody. The
ganglion cell count in the central retina was found to be
Figure 4. Increased retinal ganglion cell
survival in the RGS2−/− mice. To
determine the effect of RGS2 on retinal
ganglion cell survival in the RGS2−/−
mice, we used retinal cryosections
derived from 12 to 15-month old male
mice and immunolabeled ganglion cells
with Brn-3-specific antibody. The same
specimens were also stained with
Hoechst 33258 dye to count the total
number of cells in the ganglion cell
region. Panels A and B show Brn-3-
specific immunostaining (red), C and D
show Hoechst staining (blue), and E and
F depict the overlapping of Brn-3 and
Hoechst staining. G: Quantitative
changes in the Brn-3-positive retinal
ganglion cells between the RGS2−/−
and wild-type mice. H: Quantitative
changes in the total number of cells in
the ganglion cell region of the retina in
RGS2−/− and wild-type mice. The
RGS2−/− mice show a significant
increase in Brn-3-positive cells in the
ganglion cell region of the central retina
as compared to the wild-type mice. The
total number of cells in the ganglion cell
region of the central retina based on
Hoechst staining did not show
significant difference between two
groups of the mice. Cell number is
expressed per unit area, and values are
expressed as mean±SEM (n=4). The
asterisk indicates a p<0.05.
Abbreviations: ganglion cell layer
(GCL); inner plexiform layer (IPL);
inner nuclear layer 563 (INL); outer
nuclear layer (ONL); outer plexiform
layer (OPL). Scale bar represents 100
μm.
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significantly higher in the RGS2−/− mice compared to the
littermate wild-type mice. One plausible explanation for the
increased ganglion cell survival in the RGS2−/− mice may
relate to the decreased IOP in these mice. The RGS2 −/− mice
used in this study were 12 to 15 months of age, and aging alone
decreases retinal ganglion cell survival [55]. Moreover, aging
is a major risk factor for glaucoma [1]. Aging of C57BL/6
mice has been reported to alter gene expression profiles and
to be associated with increased oxidative stress in different
ocular tissues [56,57] Therefore, additional studies are
required to also resolve the issue of whether the increased
RGC count observed in the RGS2−/− mice is specific to aging
animals or whether a similar response can be elicited in young
animals as well. Decreased IOP in glaucoma patients has been
shown to protect ganglion cells, contributing to their survival
[58]. However, it is also important to be aware that one cannot
rule out the direct influence of Gαq/RGS2 signaling on
ganglion cell survival, independent of the effects on IOP.
Indeed, the Gαq-coupled M1 muscarinic receptors and their
agonists have been shown to increase retinal ganglion cell
survival [59]. In contrast to central retina, the retinal ganglion
cell count in the peripheral retina was found to be unaltered
in RGS2−/− mice and the reasons for this difference between
these two regions of the retina is not clear at present. Although
we cannot completely rule out the possibility of any
developmental changes in the retina of RGS2−/− mouse, based
on histological examination of the retina in these mice
compared to wild-type mice, we did not notice any distinction
between these two groups of mice. Additionally, in the
published work, although these mice have been shown to
exhibit abnormalities in T-cell activation, anxiety, aggression,
and blood pressure, there are no known developmental
changes associated with the deficiency of RGS2 [13].
In conclusion, this pilot study reveals the potential
importance of RGS2, a negative regulator of Gαq-coupled
GPCR signaling, in IOP homeostasis. Decreased IOP,
together with the morphological changes noted in the SC and
the increased actin filament staining in the CM of RGS2-
deficient mice, indicates a critical role for Gαq-mediated
signaling in the regulation of contractile activity of the CM
and TM, thereby influencing IOP homeostasis.
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